Robert Paul - 15 Jun 2021 Form 4 Insider Report for Alector, Inc. (ALEC)

Role
Chief Medical Officer
Signature
/s/ David Oh, attorney-in-fact
Issuer symbol
ALEC
Transactions as of
15 Jun 2021
Net transactions value
-$447,016
Form type
4
Filing time
21 Jun 2021, 16:15:12 UTC
Previous filing
10 Jun 2021
Next filing
06 Jul 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALEC Common Stock Options Exercise $139,536 +17,100 +6.2% $8.16 290,819 15 Jun 2021 Direct
transaction ALEC Common Stock Options Exercise $130,806 +12,900 +4.4% $10.14 303,719 15 Jun 2021 Direct
transaction ALEC Common Stock Sale $661,953 -30,000 -9.9% $22.07 273,719 15 Jun 2021 Direct F1, F2
transaction ALEC Common Stock Options Exercise $46,644 +4,600 +1.7% $10.14 278,319 16 Jun 2021 Direct
transaction ALEC Common Stock Sale $102,049 -4,600 -1.7% $22.18 273,719 16 Jun 2021 Direct F1, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALEC Employee Stock Option (right to buy) Options Exercise $0 -17,100 -15% $0.000000 97,983 15 Jun 2021 Common Stock 17,100 $8.16 Direct F4
transaction ALEC Employee Stock Option (right to buy) Options Exercise $0 -12,900 -19% $0.000000 56,467 15 Jun 2021 Common Stock 12,900 $10.14 Direct F5
transaction ALEC Employee Stock Option (right to buy) Options Exercise $0 -4,600 -8.1% $0.000000 51,867 16 Jun 2021 Common Stock 4,600 $10.14 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on May 28, 2020.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.00 to $22.305, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $22.54, inclusive.
F4 One forty-eighth (1/48th) of the shares subject to the option vested on August 2, 2018, and one forty-eighth (1/48th) of the shares subject to the option vest monthly thereafter.
F5 One-fourth (1/4th) of the shares subject to the option vested on November 1, 2019 and one forty-eighth (1/48th) of the shares vest monthly thereafter.